Basics Tevogen Bio Holdings Inc. Common Stock IPO Date: February 15, 2024 Sector: Healthcare Industry: Biotech Market Cap: $170.43M Activated in VL: True Average Daily Range Avg Daily Range: $0.12 | 5.96% Avg Daily Range (30 D): $0.03 | 2.62% Avg Daily Range (90 D): $0.04 | 3.10% Institutional Daily Volume Avg Daily Volume: 2.99M Avg Daily Volume (30 D): .85M Avg Daily Volume (90 D): .89M Trade Size Avg Trade Size (Sh.): 311 Avg Trade Size (Sh.) (30 D): 317 Avg Trade Size (Sh.) (90 D): 317 Institutional Trades Total Inst.Trades: 4 Avg Inst. Trade: $.83M Avg Inst. Trade (30 D): $.98M Avg Inst. Trade (90 D): $.98M Avg Inst. Trade Volume: .68M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $.86M Avg Closing Trade (30 D): $.98M Avg Closing Trade (90 D): $.98M Avg Closing Volume: 913.51K     News Aug 18, 2025 @ 9:50 PM Tevogen CEO Donates Personal Shares to Support Loc... Source: Dr. Ryan Saadi Aug 12, 2025 @ 3:09 PM Healthcare AI Market Explodes 38.5% Annually as Di... Source: Prnewswire Aug 11, 2025 @ 3:58 PM Tevogen Bio Oncology Reports Top-Line Revenue Fore... Source: Sadiq Khan (Chief Commercial Officer) Aug 6, 2025 @ 7:59 PM Tevogen Sees Significant Institutional Ownership G... Source: Tapan Shah Aug 5, 2025 @ 6:32 PM Tevogen.AI Expands Collaboration With Databricks a... Source: Mittul Mehta Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.19 $-.03 $-.07 Diluted EPS $-.19 $-.03 $-.07 Revenue $ -.04M $ -.04M $ M Gross Profit $ $ $ Net Income / Loss $ -31.2M $ -5.5M $ -10.37M Operating Income / Loss $ -31.25M $ -5.44M $ -10.36M Cost of Revenue $ $ $ Net Cash Flow $ M $ M $ M PE Ratio